Philips Gains FDA Clearance for CT Imaging Solutions

Any of Royal Philips’ CT imaging models now can be used for lung cancer screening, the company announced Tuesday, after the FDA cleared its suite of CT imaging solutions.

The portfolio includes 27 CT and PET/CT models that provide customized management of the radiation dose and advanced image data sharing and analytics, according to the company. — Anisa Jibrell